| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01659242 Details | 2014-12-02 Interventional | 4 | 1 | Leflunomide Methotrexate Sulfasalazine Arthritis Arthritis, Rheu… Rheumatoid Arth… | - - | |||
| NCT00729404 2008-001198-13 Details | 2014-12-02 Interventional | 2 | 17 | Ethinyl Estradi… Femovan Gestodene Contraception Ovulation Inhib… | - - | |||
| NCT01329549 Details | 2014-11-27 Interventional | 1 | 2 | Carboplatin Nintedanib Ovarian Neoplas… | - The trial was prematurely terminated because of worldwide disruption of pegylated liposomal doxorubicin (PLD) supplies. | |||
| NCT00940784 Details | 2014-11-26 Interventional | 2 | 0 | Aspirin Clopidogrel Polycythemia Polycythemia Ve… | Could not get drug - | |||
| NCT00798304 2008-001457-18 Details | 2014-11-26 Interventional | 2 | 46 | Vaccines Meningitis Meningitis, Men… | Following program review within Pfizer, decision was made not to go ahead with this study. This
study is cancelled Immunogenicity results were not reported because the study was terminated due to the reactogenicity profile of the vaccine in infants prior to the first scheduled post-vaccination blood draw and no immunogenicity data were collected. | |||
| NCT02048475 2009-014620-36 Details | 2014-11-25 Interventional | 4 | 0 | Desflurane Anesthesia | administrative reasons. - | |||
| NCT00333229 2004-002831-14 Details | 2014-11-25 Interventional | 4 | 11 | Zoledronic Acid Breast Neoplasm… Primary Hormone… | Due to rare patient population, planned number of patients could not be recruited in a
reasonable timeframe. Recruitment was stopped prematurely. - | |||
| NCT01238029 Details | 2014-11-21 Interventional | 1 | 12 | Capecitabine Lapatinib Vinorelbine Breast Neoplasm… Failure or Cont… First or Second… HER2 Positive Metastatic Brea… | new methods of treatment, no more patients appilicable for study - | |||
| NCT01464671 Details | 2014-11-20 Interventional | 4 | 260 | Bivalirudin Heparin Coronary Artery… Coronary Diseas… Myocardial Isch… | DSMB halted the study early due to futility. There were no safety concerns. - | |||
| NCT01465815 Details | 2014-11-19 Interventional | 1/2 | 0 | Erlotinib Hydro… Carcinoma Carcinoma, Squa… Recurrence Recurrent Skin … Recurrent Squam… Squamous Cell C… Stage III Squam… Stage IVA Squam… Stage IVB Squam… | Drug manufacturer, Astellas Pharma, informed us that safety and efficacy of Erlotinib and
OSI-906 in other oncology studies was determined to be unfavorable. - | |||
| NCT02234869 Details | 2014-11-17 Interventional | 4 | 0 | Interferon beta… Interferon beta… Interferon-beta Interferons Multiple Sclero… Sclerosis Relapsing Multi… | Due to a change in Biogen Idec's medical research plans. - | |||
| NCT01650805 Details | 2014-11-17 Interventional | 3 | 307 | Imatinib Mesyla… Ponatinib Leukemia Leukemia, Myelo… Leukemia, Myelo… Chronic Myeloid… | Study terminated based on evaluation of safety data. Trial was discontinued early. | |||
| NCT00708357 Details | 2014-11-17 Interventional | 1 | 12 | omega-N-Methyla… Ocular Physiolo… Regional Blood … | - - | |||
| NCT00024687 Details | 2014-11-14 Interventional | 1 | 0 | Immunotoxins Neoplasms | Support withdrawn - Study continued by NCI - see record NCT00006981 - | |||
| NCT01006096 Details | 2014-11-10 Interventional | 2 | 0 | Erlotinib Hydro… Psoriasis | IND not obtained - | |||
| NCT01966575 Details | 2014-11-06 Interventional | 4 | 0 | Medroxyprogeste… Medroxyprogeste… Progestins Infertility Polycystic Ovar… | Recent findings suggest that letrozole may be a superior Clomiphene Citrate. - | |||
| NCT01737359 Details | 2014-11-05 Interventional | 2 | 2 | Tenofovir Acquired Immuno… HIV Infections Human Immunodef… | - - | |||
| NCT01417481 Details | 2014-11-05 Interventional | 2 | 13 | Glycine Cystic Fibrosis Fibrosis | Some of the researchers finished their participation in the study. - | |||
| NCT01092858 2009-017139-16 Details | 2014-11-05 Interventional | 4 | 4 | Methyltestoster… Testosterone Testosterone 17… Testosterone en… Testosterone un… Hypogonadism | - - | |||
| NCT01088763 Details | 2014-11-05 Interventional | 1 | 129 | 2,2-dimethyl-N-… Dexamethasone Adamantinoma Adenoma Adenoma, Acidop… Adenoma, Basoph… Adenoma, Chromo… Astrocytoma Choriocarcinoma Choroid Plexus … Craniopharyngio… Endodermal Sinu… Ependymoma Germinoma Glioma Leukemia Leukemia, Large… Leukemia, Lymph… Leukemia, T-Cel… Lymphoma Lymphoma, Large… Lymphoma, Non-H… Lymphomatoid Gr… Medulloblastoma Meningioma Neoplasms Neuroectodermal… Neuroectodermal… Oligodendroglio… Pinealoma Pituitary Disea… Pituitary Neopl… Precursor Cell … Prolactinoma Recurrence Rhabdoid Tumor Spinal Cord Neo… Teratoma Childhood Atypi… Childhood Centr… Childhood Centr… Childhood Centr… Childhood Centr… Childhood Centr… Childhood Choro… Childhood Crani… Childhood Epend… Childhood Grade… Childhood Grade… Childhood Grade… Childhood Infra… Childhood Medul… Childhood Mixed… Childhood Oligo… Childhood Supra… Gonadotroph Ade… Pituitary Basop… Pituitary Chrom… Pituitary Eosin… Prolactin Secre… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Child… Recurrent Pitui… Recurrent/Refra… T-cell Childhoo… T-cell Large Gr… TSH Secreting A… Unspecified Chi… | - - |